Related Experiment Videos
Erythropoietic protoporphyria: treatment with antioxidants and potential cure with gene therapy
1Department of Medicine, Channing Laboratory, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Methods in Enzymology
|July 25, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Amelioration of the metabolic defect in erythropoietic protoporphyria by expression of human ferrochelatase in cultured cells.
The Journal of investigative dermatology·1995
A double-blind study of cysteine photoprotection in erythropoietic protoporphyria.
Photodermatology, photoimmunology & photomedicine·1994
Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases.
Annals of the New York Academy of Sciences·1993
Protective role of butylated hydroxytoluene and certain carotenoids in photocarcinogenesis.
Photochemistry and photobiology·1991
Current methods and applications in the study of 1-Deoxy-D-xylulose 5-phosphate synthase (DXPS).
Methods in enzymology·2026
Biochemical and cryo-EM studies of the pyruvate dehydrogenase complex from native cell extracts.
Methods in enzymology·2026
Use of dihydroxyacetone synthase for the assimilation of methanol in E. coli.
Methods in enzymology·2026
Methotrexate Modulates Polymorphonuclear Neutrophil Function Through Reduced Chemotaxis and Increased LOX-1 Expression.
Immunity, inflammation and disease·2026
Non-invasive functional neurosurgery revisited: The emerging role of MRgFUS in neuropsychiatric disorders.
Dental and medical problems·2026
Switching to Pegmolesatide in Maintenance Dialysis: Real-World Hemoglobin Response, Temporal Dynamics, and Modality-Specific Predictors.
Drug design, development and therapy·2026
Tetrahedral Framework Nucleic Acid-Based Small RNA Delivery: Prospects and Challenges in Bone and Cartilage Regeneration.
Advanced healthcare materials·2026
Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis.
Arthritis & rheumatology (Hoboken, N.J.)·2026